Effect of 32P Application Combined with Timolol Maleate on Circulating Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Children with Cutaneous Hemangioma
Effect of 32P Application Combined with Timolol Maleate on Circulating Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Children with Cutaneous Hemangioma
Zongliang Li1, Rongxin Ma2,*, Yan Wei1 and Jianghua Zuo3
Fig. 1.
qRT-PCR analysis on mRNA expression of VEGF, TGF-b.
Fig. 2.
Western blot analysis of protein expression of bFGF and IL-6.
Fig. 3.
Comparison of children in the combined treatment group before and after treatment.
June 2023
Vol. 55, Iss. 3, Pages 1003-1500
